The London Business School's Middle East Market Insights 2020

CIC's Michael Anstey will join the life sciences panel discussion at this year's Middle East Market Insights event on 10 November at 13.15 (UK time). 

The panel:

  • Facilitator: Lynsey Stone, Mubadala Healthcare
  • Camilla Macapili Languille, Head of Pharma & MedTech, Mubadala
  • John Schoellerman, SVP Corporate Development and Investment, Oxford Nanopore Technologies
  • Rami Rajab, Chairman of Mecomed and Chairman of LivaNova's International Fellowship
  • Michael Anstey, Partner, Cambridge Innovation Capital

 

Find out more about the London Business School

 

Dr Michael Anstey is a Partner at CIC specialising in life science investments

Before joining CIC he was a Principal in the Healthcare Practice Area at The Boston Consulting Group’s (BCG) Toronto office. Michael has experience in advising multinational businesses across North America, Europe, India, and Japan. Michael was also co-founder of an early stage biotechnology company focused on developing small molecule drugs that target protein-protein interactions implicated in disease.

Michael manages CIC's investments in Bicycle Therapeutics, Congenica, Immutrin, PredictImmune, PolyProx Therapeutics, Sense, Start Codon and Storm Therapeutics.